CN100375610C - Dripping pills of honey suckle and its preparation method - Google Patents
Dripping pills of honey suckle and its preparation method Download PDFInfo
- Publication number
- CN100375610C CN100375610C CNB2005100721788A CN200510072178A CN100375610C CN 100375610 C CN100375610 C CN 100375610C CN B2005100721788 A CNB2005100721788 A CN B2005100721788A CN 200510072178 A CN200510072178 A CN 200510072178A CN 100375610 C CN100375610 C CN 100375610C
- Authority
- CN
- China
- Prior art keywords
- polyethylene glycol
- substrate
- mixed
- matrix
- drug extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention discloses a medicine composition which has the function of clearing heat and toxin, and is used for the treatment of hotness, hydrodipsia, sores, furuncles, erupted fetal disease and other diseases. The present invention has the purpose of complementing the deficiency of the existing oral medicine preparations used for the treatment of the diseases, and provides honeysuckle dripping pills which are oral medicine preparations having the advantages of high bioavailability, quick medicine release, rapid effect, high medicine content, accurate administration measurement, convenient administration, low price and no pollution during production. The honeysuckle dripping pills of the present invention are prepared by taking Chinese medicine honeysuckle as raw material and preparing the raw material together with a medicinal carrier serving as a matrix.
Description
Technical field
The present invention relates to a kind of antipyretic and antidote functions that has, it is thirsty to be used for summer-heat, furuncle, and the pharmaceutical composition of treatment for diseases such as infantile carbuncle is a kind of drug composition oral preparation that feedstock production forms with the Chinese medicine Flos Lonicerae particularly.
Background technology
According to drug standard WS promulgated by the ministries or commissions of the Central Government
3The Liquor Flos Lonicerae Distillata that the preparation method that provides among-the B-0754-91 is prepared from is a kind of antipyretic and antidote functions that has, and it is thirsty to be used for summer-heat, furuncle, the oral liquid of treatment for diseases such as infantile carbuncle is through clinical verification, determined curative effect is the common drug that clinical and family is used for the treatment of above-mentioned disease.
Following WS
3-B-0754-91 is prescription and technology and the brief description that provides in the drug standard:
Prescription: Flos Lonicerae 100g
Method for making: extracting honeysuckle, use vapor distillation, the Flos Lonicerae of every 1000g is collected distillate 1600g.Get distillate, filter, embedding, sterilization, promptly.
Function cures mainly: heat-clearing and toxic substances removing.It is thirsty to be used for summer-heat. furuncle, infantile carbuncle.
Owing to reasons such as technologies of preparing, the oral formulations of most drug, especially the oral formulations of Chinese medicine, exist all after taking that dissolve scattered time limit is long, dissolution is low, absorption is relatively poor, problem such as liver sausage first pass effect and bioavailability are lower, thereby influence the performance of drug effect, also directly affect therapeutic effect.It is low that the syrups preparation also has a medicament contg, and dose is not accurate enough and take inconvenient shortcoming.
In addition, conventional peroral dosage form is as tablet, capsule, granule (electuary) etc., in preparation process because the technology of granulation is arranged, therefore can produce bigger dust pollution, can staff's health be worked the mischief to a certain extent, also can cause certain pollution simultaneously to environment.Moreover, the complex manufacturing of conventional oral formulations, production cost is higher, thereby patient's drug cost is also improved thereupon, is unfavorable for improving the ability of seeking medical advice of extensive patients, also is unfavorable for improving the general health level of society.
Summary of the invention
Purpose of the present invention, be to replenish that existing to be used for summer-heat thirsty, furuncle, the deficiency of the oral drug preparation of treatment for diseases such as infantile carbuncle provides a kind of bioavailability height, and has a quick release, quick produce effects, medicament contg height, accurate measurement, taking convenience, cheap, and free of contamination aborning oral formulations dripping pills of honey suckle.Dripping pills of honey suckle involved in the present invention is a raw material with the Chinese medicine Flos Lonicerae, is prepared from the pharmaceutically suitable carrier as substrate.Be prepared by the following technical solutions, can obtain dripping pills of honey suckle involved in the present invention:
[preparation method]
1. the preparation of drug extract: with g or kg is unit, and extracting honeysuckle is an amount of, uses vapor distillation, and the Flos Lonicerae of every 100g is collected distillate 1600g, get distillate, filter, it is 1.3～1.35 thick paste that filtrate is condensed into relative density, or continue to make drying, be ground into dry powder, promptly;
2. substrate: the mixture of one or more in pharmaceutically suitable carrier such as polyethylene glycols, sorbitol anhydride class, polyoxyethylene sorbitol acid anhydride class, polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, sodium lauryl sulphate, stearic acid, sodium stearate, glycerin gelatine, Lac;
3. proportioning: with g or kg is unit, by weight, and drug extract: substrate=1: 1～1: 9;
4. according to the given ratio of prescription, accurately take by weighing drug extract and substrate, be placed on heating while stirring in the heating container, standby until the fused solution that obtains containing drug extract and substrate and/or emulsion and/or suspension;
5. adopt homemade or general drop pill machine (as the TZDW-1 type drop pill machine of Changzheng Tianmin High Science ﹠ Technology Co., Ltd., Beijing's production), and the temperature control system of adjustment drop pill machine, make the water dropper temperature heating of drop pill machine and remain on (50～90) ℃, the temperature cooling of condensing agent also remains on (40～-5) ℃;
6. when treating that the temperature of condensing agent in dropping-pill machine head and the condensation column is stable respectively and reaching desired state of temperature, to contain the fused solution of drug extract and substrate and/or emulsion and/or suspension places in the water dropper jar of drop pill machine, splash in the condensing agent, condensing agent can be any one in liquid paraffin, methyl-silicone oil, the vegetable oil;
7. will shrink the drop pill taking-up of molding by the outlet of drop pill machine, remove the surface condensation agent, be drying to obtain.
[beneficial effect]
According to drug standard WS promulgated by the ministries or commissions of the Central Government
3The Liquor Flos Lonicerae Distillata that the preparation method that provides among-the B-0754-91 is prepared from is a kind of antipyretic and antidote functions that has, and it is thirsty to be used for summer-heat, furuncle, the oral liquid of treatment for diseases such as infantile carbuncle is through clinical verification, determined curative effect is the common drug that clinical and family is used for the treatment of above-mentioned disease.
Owing to reasons such as technologies of preparing, the oral formulations of most drug, especially the oral formulations of Chinese medicine, exist all after taking that dissolve scattered time limit is long, dissolution is low, absorption is relatively poor, problem such as liver sausage first pass effect and bioavailability are lower, thereby influence the performance of drug effect, also directly affect therapeutic effect.It is low that the syrups preparation also has a medicament contg, and dose is not accurate enough and take inconvenient shortcoming.
In addition, conventional peroral dosage form is as tablet, capsule, granule (electuary) etc., in preparation process because the technology of granulation is arranged, therefore can produce bigger dust pollution, can staff's health be worked the mischief to a certain extent, also can cause certain pollution simultaneously to environment.Moreover, the complex manufacturing of conventional oral formulations, production cost is higher, thereby patient's drug cost is also improved thereupon, is unfavorable for improving the ability of seeking medical advice of extensive patients, also is unfavorable for improving the general health level of society.
Dripping pills of honey suckle involved in the present invention is compared with the Liquor Flos Lonicerae Distillata has following beneficial effect:
1. dripping pills of honey suckle involved in the present invention; utilize surfactant to be substrate; make solid dispersion with the extract that contains the honey suckle active ingredient, make medicine be molecule, colloid or microcrystalline state and be scattered in the substrate, the total surface area of medicine increases; and substrate is hydrophilic; medicine is had wetting action, can make that medicine is rapidly molten to loose into microgranule or solution, thereby make the dissolving of medicine and absorb and accelerate; thereby improved bioavailability, brought into play efficient, quick-acting effects etc.
2. dripping pills of honey suckle involved in the present invention, contact promptly with saliva and to dissolve rapidly, and absorb by oral mucosa, not only rapid-action, and the influence of not taken food. be all can containing to take after meal ante cibum, can not produce any residual harmful substance yet, thereby make that patient's medication is safer, also have medication convenience, characteristic of accurate simultaneously at gastric.
3. dripping pills of honey suckle involved in the present invention mixes the extract that contains active constituents of medicine mutually with molten matrix, splashes in the not miscible condensed fluid and makes.Therefore, the stability of drug height, not facile hydrolysis, oxidation, and the operation be under liquid state, to carry out, no dust pollution is not subject to the influence of crystal formation, thereby has guaranteed the quality of medicine, has increased stability.
4. production technology, the equipment of preparation drop pill are simple, easy to operate, the automaticity height, and labor intensity is low, the production efficiency height.Workshop does not have dust simultaneously, helps labor protection and environmental protection yet.
5. the production cost of preparation drop pill is usually with about 50% of other oral formulations of kind, and compares with oral liquid, and the dosage of drop pill is accurate, thereby makes the patient take metering control easily.
The specific embodiment
Now with several groups of specific embodiments, be described further with regard to the preparation method of dripping pills of honey suckle of the present invention.
[first group: the test of single-matrix]
1. raw material: it is standby to make the extract dry powder that contains the honey suckle active ingredient earlier according to [preparation method 1];
2. substrate: Polyethylene Glycol
1000, Polyethylene Glycol
4000, Polyethylene Glycol
6000, Polyethylene Glycol
10000, Polyethylene Glycol
20000, span 40, polyoxyethylene stearate 40 esters, poloxamer, sodium lauryl sulphate, stearic acid, sodium stearate, glycerin gelatine, Lac;
3. proportioning: with g or kg is unit, by weight, and drug extract: substrate=1: 1～1: 9;
4. the process that provides according to [preparation method] 4～7 is prepared, and can obtain the dripping pills of honey suckle of different size.
[result of the test]
Test 1: for observe drug extract and different substrates when 1: 1 the proportioning prepared dripping pills of honey suckle in qualitative difference, according to 1: 1 ratio, with drug extract respectively with Polyethylene Glycol
1000, Polyethylene Glycol
4000, Polyethylene Glycol
6000, Polyethylene Glycol
10000, Polyethylene Glycol
20000, pharmaceutically suitable carrier such as span 40, polyoxyethylene stearate 40 esters, poloxamer, sodium lauryl sulphate, stearic acid, sodium stearate, glycerin gelatine, Lac matches, be prepared according to the step of stipulating in the preparation method, can obtain 16 pharmaceutical compositions experiments that contain drug extract and different substrates, and obtain 16 groups of different experimental results and see Table 1.
Test 2: for observe drug extract and different substrates when 1: 3 the proportioning prepared dripping pills of honey suckle in qualitative difference, according to 1: 3 ratio, with drug extract respectively with Polyethylene Glycol
1000, Polyethylene Glycol
4000, Polyethylene Glycol
6000, Polyethylene Glycol
10000, Polyethylene Glycol
20000, pharmaceutically suitable carrier such as span 40, polyoxyethylene stearate 40 esters, poloxamer, sodium lauryl sulphate, stearic acid, sodium stearate, glycerin gelatine, Lac matches, be prepared according to the step of stipulating in the preparation method, can obtain 16 pharmaceutical compositions experiments that contain drug extract and different substrates, and obtain 16 groups of different experimental results and see Table 2.
Test 3: for observe drug extract and different substrates when 1: 9 the proportioning prepared dripping pills of honey suckle in qualitative difference, according to 1: 9 ratio, with drug extract respectively with Polyethylene Glycol
1000, Polyethylene Glycol
4000, Polyethylene Glycol
6000, Polyethylene Glycol
10000, Polyethylene Glycol
20000, pharmaceutically suitable carrier such as span 40, polyoxyethylene stearate 40 esters, poloxamer, sodium lauryl sulphate, stearic acid, sodium stearate, glycerin gelatine, Lac matches, be prepared according to the step of stipulating in the preparation method, can obtain 16 pharmaceutical compositions experiments that contain drug extract and different substrates, and obtain 16 groups of different experimental results and see Table 3.
[second group: the test of mixed-matrix]
1. raw material: it is standby to make the extract dry powder that contains the honey suckle active ingredient earlier according to [preparation method 1];
2. substrate:
2.1 Polyethylene Glycol---English name Macrogol,
2.2 polyoxyethylene stearate 40 esters---English name Polyoxyl (40) Stearate,
Molecular formula is with C
17H
35COO (CH
2CH
2O)
nH represents that n is about 40,
2.3 poloxamer---English name Poloxamer, polyoxyethylene poly-oxygen propylene aether,
Molecular formula HO (C
2H
4O)
a(C
3H
6O)
b(C
2H
4O)
cH,
2.4 the sodium salt of the starch carboxymethyl ester that carboxymethyl starch sodium-English name Carboxymethylstach Sodium, starch generate with the monoxone effect under alkali condition,
2.5 betacyclodextrin---English name Betacyclodextrin, molecular formula C
6H
10O
5, this product is that ring dextrin glucosyl transferase acts on 7 glucoses that starch generates with α-1, the bonded cyclic oligosaccharide of 4-glycosidic bond;
3. proportioning: with g or kg is unit, by weight, and drug extract: substrate=1: 1～1: 9;
4. the process that provides according to [preparation method] 4～7 is prepared, and can obtain the dripping pills of honey suckle of different size.
[result of the test]
Test 4: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared dripping pills of honey suckle when 1: 1 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 1 mixed evenly as mixed-matrix, according to 1: 1 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experiments and the results are shown in Table 4.
Test 5: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared dripping pills of honey suckle when 1: 3 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 1 mixed evenly as mixed-matrix, according to 1: 3 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experiments and the results are shown in Table 5.
Test 6: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared dripping pills of honey suckle when 1: 9 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 1 mixed evenly as mixed-matrix, according to 1: 9 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experiments and the results are shown in Table 6.
Test 7: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared dripping pills of honey suckle when 1: 1 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 5 mixed evenly as mixed-matrix, according to 1: 1 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experiments and the results are shown in Table 7.
Test 8: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared dripping pills of honey suckle when 1: 3 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 5 mixed evenly as mixed-matrix, according to 1: 3 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experiments and the results are shown in Table 8.
Test 9: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared dripping pills of honey suckle when 1: 9 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 5 mixed evenly as mixed-matrix, according to 1: 9 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experiments and the results are shown in Table 9.
Test 10: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared dripping pills of honey suckle when 1: 1 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 10 mixed evenly as mixed-matrix, according to 1: 1 ratio drug extract is mixed mutually with 4 kinds of different mixed-matrixes respectively again and make evenly, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experiments and the results are shown in Table 10.
Test 11: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared dripping pills of honey suckle when 1: 3 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 10 mixed evenly as mixed-matrix, according to 1: 3 ratio drug extract is mixed mutually with 4 kinds of different mixed-matrixes respectively again and make evenly, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experiments and the results are shown in Table 11.
Test 12: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared dripping pills of honey suckle when 1: 9 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 10 mixed evenly as mixed-matrix. according to 1: 9 ratio drug extract is mixed mutually with 4 kinds of different mixed-matrixes respectively again and makes evenly, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experiments and the results are shown in Table 12.
The group practices of table 1 drug extract and single-matrix (drug extract: substrate=1: 1)
| The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
| Polyethylene Glycol 1000 | 50.0 | 68 | <30 | >10 | + |
| Polyethylene Glycol 4000 | 50.0 | 88 | <30 | <10 | ++ |
| Polyethylene Glycol 6000 | 50.0 | 89 | <30 | <10 | ++ |
| Polyethylene Glycol 10000 | 50.0 | 89 | <30 | <10 | ++ |
| Polyethylene Glycol 20000 | 50.0 | 89 | <30 | <10 | ++ |
| Span 40 | 50.0 | 65 | <30 | >10 | ++ |
| Polyoxyethylene stearate 40 esters | 50.0 | 89 | <30 | <10 | + |
| Poloxamer | 50.0 | 89 | <30 | <10 | ++ |
| Sodium lauryl sulphate | 50.0 | 74 | >30 | >10. | ++. |
| Stearic acid | 50.0 | 63 | >30 | >10 | ++ |
| Sodium stearate | 50.0 | 63 | >30 | >10 | ++ |
| Glycerin gelatine | 50.0 | 61 | >30 | >10 | + |
| Lac | 50.0 | 62 | >30 | >10 | + |
The group practices of table 2 drug extract and single-matrix (drug extract: substrate=1: 3)
| The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
| Polyethylene Glycol 1000 | 25.0 | 74 | <30 | >10 | + |
| Polyethylene Glycol 4000 | 25.0 | 90 | <30 | <10 | ++ |
| Polyethylene Glycol 6000 | 25.0 | 90 | <30 | <10 | +++ |
| Polyethylene Glycol 10000 | 25.0 | 90 | <30 | <10 | +++ |
| Polyethylene Glycol 20000 | 25.0 | 89 | <30 | <10 | +++ |
| Span 40 | 25.0 | 75 | <30 | >10 | +++ |
| Polyoxyethylene stearate 40 esters | 25.0 | 90 | <30 | <10 | ++ |
| Poloxamer | 25.0 | 91 | <30 | <10 | +++ |
| Sodium lauryl sulphate | 25.0 | 77 | <30 | >10 | ++ |
| Stearic acid | 25.0 | 76 | >30 | >10 | +++ |
| Sodium stearate | 25.0 | 74 | >30 | >10 | +++ |
| Glycerin gelatine | 25.0 | 73 | >30 | >10 | +++ |
| Lac | 25.0 | 73 | >30 | >10 | +++ |
The group practices of table 3 drug extract and single-matrix (drug extract: substrate=1: 9)
| The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
| Polyethylene Glycol 1000 | 10.0 | 83 | <30 | >10 | ++ |
| Poly-740 | 10.0 | 91 | <30 | <10 | ++ |
| Polyethylene Glycol 6000 | 10.0 | 91 | <30 | <10 | +++ |
| Polyethylene Glycol 10000 | 10.0 | 91 | <30 | <10 | +++ |
| Polyethylene Glycol 20000 | 10.0 | 90 | <30 | <10 | +++ |
| Span 40 | 10.0 | 78 | <30 | >10 | +++ |
| Polyoxyethylene stearate 40 esters | 10.0 | 90 | <30 | <10 | ++ |
| Poloxamer | 10.0 | 91 | <30 | <10 | +++ |
| Sodium lauryl sulphate | 10.0 | 78 | <30 | >10 | +++ |
| Stearic acid | 10.0 | 78 | >30 | >10 | +++ |
| Sodium stearate | 10.0 | 73 . | >30 | >10 | +++ |
| Glycerin gelatine | 10.0 | 73 | >30 | >10 | +++ |
| Lac | 10.0 | 74 | >30 | >10 | +++ |
The group practices of table 4 drug extract and mixed-matrix (drug extract: mixed-matrix=1: 1)
| The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
| Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 1 | 50 | 84 | <30 | >10 | ++ |
| Poloxamer: Polyethylene Glycol=1: 1 | 50 | 85 | <30 | >10 | ++ |
| Carboxymethyl starch sodium: Polyethylene Glycol=1: 1 | 50 | 84 | <30 | >10 | ++ |
| Betacyclodextrin: Polyethylene Glycol=1: 1 | 50 | 78 | <30 | >10 | + |
The group practices of table 5 drug extract and mixed-matrix (drug extract: mixed-matrix=1: 3)
| The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
| Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 1 | 25 | 89 | <30 | <1 | +++ |
| Poloxamer: Polyethylene Glycol=1: 1 | 25 | 90 | <30 | <10 | +++ |
| Carboxymethyl starch sodium: Polyethylene Glycol=1: 1 | 25 | 87 | <30 | <10 | +++ |
| Betacyclodextrin: Polyethylene Glycol=1: 1 | 25 | 83 | <30 | >10 | ++ |
The group practices of table 6 drug extract and mixed-matrix (drug extract: mixed-matrix=1: 9)
| The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
| Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 1 | 10 | 90 | <30 | <10 | +++ |
| Poloxamer: Polyethylene Glycol=1: 1 | 10 | 90 | <30 | <10 | +++ |
| Carboxymethyl starch sodium: Polyethylene Glycol=1: 1 | 10 | 88 | <30 | >10 | +++ |
| Betacyclodextrin: Polyethylene Glycol=1: 1 | 10 | 84 | <30 | >10 | +++ |
The group practices of table 7 drug extract and mixed-matrix (drug extract: mixed-matrix=1: 1)
| The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
| Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 5 | 50 | 91 | <30 | <10 | +++ |
| Poloxamer: Polyethylene Glycol=1: 5 | 50 | 91 | <30 | <10 | +++ |
| Carboxymethyl starch sodium: Polyethylene Glycol=1: 5 | 50 | 91 | <30 | <10 | +++ |
| Betacyclodextrin: Polyethylene Glycol=1: 5 | 50 | 87 | <30 | <10 | ++ |
The group practices of table 8 drug extract and mixed-matrix (drug extract: mixed-matrix=1: 3)
| The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
| Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 5 | 25 | 90 | <30 | <10 | +++ |
| Poloxamer: Polyethylene Glycol=1: 5 | 25 | 90 | <30 | <10 | +++ |
| Carboxymethyl starch sodium: Polyethylene Glycol=1: 5 | 25 | 91 | <30 | <10 | +++ |
| Betacyclodextrin: Polyethylene Glycol=1: 5 | 25 | 88 | <30 | <10 | +++ |
The group practices of table 9 drug extract and mixed-matrix (drug extract: mixed-matrix=1: 9)
| The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
| Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 5 | 10 | 93 | <30 | <10 | +++ |
| Poloxamer: Polyethylene Glycol=1: 5 | 10 | 93 | <30 | <10 | +++ |
| Carboxymethyl starch sodium: Polyethylene Glycol=1: 5 | 10 | 92 | <30 | <10 | +++ |
| Betacyclodextrin: Polyethylene Glycol=1: 5 | 10 | 89 | <30 | <10 | +++ |
The group practices of table 10 drug extract and mixed-matrix (drug extract: mixed-matrix=1: 1)
| The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
| Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 10 | 50 | 91 | <30 | <10 | +++ |
| Poloxamer: Polyethylene Glycol=1: 10 | 50 | 90 | <30 | <10 | +++ |
| Carboxymethyl starch sodium: Polyethylene Glycol=1: 10 | 50 | 88 | <30 | <10 | +++ |
| Betacyclodextrin: Polyethylene Glycol=1: 10 | 50 | 88 | <30 | >10 | +++ |
The group practices of table 11 drug extract and mixed-matrix (drug extract: mixed-matrix=1: 3)
| The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
| Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 10 | 25 | 90 | <30 | <10 | +++ |
| Poloxamer: Polyethylene Glycol=1: 10 | 25 | 91 | <30 | <10 | +++ |
| Carboxymethyl starch sodium: Polyethylene Glycol=1: 10 | 25 | 88 | <30 | <10 | +++ |
| Betacyclodextrin: Polyethylene Glycol=1: 10 | 25 | 87 | <30 | <10 | +++ |
The group practices of table 12 drug extract and mixed-matrix (drug extract: mixed-matrix=1: 9)
| The substrate title | Effective ingredient (%) | Rounding rate (%) | Dissolve scattered time limit (minute) | The ball method of double differences different (%) | Hardness |
| Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 10 | 10 | 90 | <30 | <10 | +++ |
| Poloxamer: Polyethylene Glycol=1: 10 | 10 | 90 | <30 | <10 | +++ |
| Carboxymethyl starch sodium: Polyethylene Glycol=1: 10 | 10 | 89 | <30 | <10 | +++ |
| Betacyclodextrin: Polyethylene Glycol=1: 10 | 10 | 89 | <30 | <10 | +++ |
1. can be seen by the result in the table: when the ratio of drug extract and substrate was 1: 1, its rounding rate, the ball method of double differences was different and index such as hardness is all undesirable, and dissolve scattered time limit influenced not obvious.
2. when the ratio of drug extract and substrate is 1: 3, the rounding rate, the ball method of double differences is different and index such as hardness slightly all begins to enter preferable state.
3. when the ratio of drug extract and substrate is 1: 9, the rounding rate, the ball method of double differences is different and index such as hardness improves not obvious.
4. the general effect of composite interstitial substance is better than single-matrix.
5. the hardness method for expressing in the subordinate list adopts drop pill is placed on the glass plate, press...withes one's finger it, observes its metamorphosis."+" expression flicking promptly is out of shape, " ++ " expression distortion of firmly pressing, and " +++" expression is indeformable by it.
Claims (2)
1. a dripping pills of honey suckle is a raw material with the Flos Lonicerae, is prepared from the pharmaceutically suitable carrier as substrate, it is characterized in that:
(1) be unit with g or kg, extracting honeysuckle is an amount of, use vapor distillation, the Flos Lonicerae of every 100g is collected distillate 1600g, gets distillate, filter, it is 1.3～1.35 thick paste that filtrate is condensed into relative density, or continues to make drying, is ground into dry powder, promptly get the extract that contains effective ingredient of honeysuckle, standby;
(2) described substrate is the mixture of Polyethylene Glycol and polyoxyethylene stearate 40 esters or carboxymethyl starch sodium, by weight, the mixed proportion of polyoxyethylene stearate 40 esters or carboxymethyl starch sodium and Polyethylene Glycol is 1: 1～1: 10, and by weight, the ratio of described extract and substrate is 1: 3;
(3) according to aforementioned proportion, accurately take by weighing described extract and substrate, be placed in the heating container heating while stirring, standby until the fused solution that obtains containing described extract and substrate and/or emulsion and/or suspension;
(4) temperature control system of adjustment drop pill machine makes the water dropper heating of drop pill machine and maintains the temperature at 50 ℃～90 ℃, and the condensing agent cooling also maintains the temperature at 40 ℃～-5 ℃;
When (5) temperature for the treatment of dropping-pill machine head and condensing agent reaches described state respectively, will contain fused solution and/or the emulsion and/or the suspension of described extract and substrate, place in the water dropper jar of drop pill machine, and splash in the condensing agent and shrink molding promptly.
2. dripping pills of honey suckle as claimed in claim 1 is characterized in that: described condensing agent be methyl-silicone oil or/and liquid paraffin or/and vegetable oil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100721788A CN100375610C (en) | 2005-05-26 | 2005-05-26 | Dripping pills of honey suckle and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100721788A CN100375610C (en) | 2005-05-26 | 2005-05-26 | Dripping pills of honey suckle and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1698784A CN1698784A (en) | 2005-11-23 |
| CN100375610C true CN100375610C (en) | 2008-03-19 |
Family
ID=35475138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100721788A Expired - Fee Related CN100375610C (en) | 2005-05-26 | 2005-05-26 | Dripping pills of honey suckle and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100375610C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105596308A (en) * | 2016-02-03 | 2016-05-25 | 深圳市先康达生物科技有限公司 | Honeysuckle dropping pills and preparation method thereof |
-
2005
- 2005-05-26 CN CNB2005100721788A patent/CN100375610C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1698784A (en) | 2005-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100542516C (en) | Dropping pill of folium ilicis hainanensis and preparation method thereof | |
| CN1322855C (en) | Oral drop pill in use for clearing away heat and toxic material and preparation method | |
| CN100382785C (en) | Cough suppressing phlegm transforming drip pill and its preparation method | |
| CN100382786C (en) | Bastard feverfew throat clearing drip pill and its preparation method | |
| CN1315471C (en) | Basis-reinforcing eyesight-improving dropping pill for treating eye disease and its preparing method | |
| CN100367936C (en) | Oral drop pill in use for clearing sway heat and toxic material, relieving inflammation and dysentery, and preparation method | |
| CN100348174C (en) | Oral drop pill in use for clearing away heat and toxic material, relieving inflammation and alleviating pain, and preparation method | |
| CN100364513C (en) | 'Gansu' dripping pills for treating hepatitis and its preparation method | |
| CN100375610C (en) | Dripping pills of honey suckle and its preparation method | |
| CN100367935C (en) | Oral drop pills in use for treating diseases of bacterial infection and preparation method | |
| CN1315470C (en) | Compound liver-benefiting dropping pill for treating hepatitis and its preparing method | |
| CN100358531C (en) | Glycyrrhizin drop pills and preparation method thereof | |
| CN1315468C (en) | Liver-benefiting dropping pill prepared from total neterosides of swertia mileensis, and its preparing method | |
| CN1315469C (en) | Golden gallbladder-normalizing dropping pill for relaxing-liver and normalizing gallbladder, and its preparing method | |
| CN100348177C (en) | Two kinds of oral drip pills for treating tracheitis and its preparation method | |
| CN100348175C (en) | Bistort drop pill and preparation method | |
| CN1315465C (en) | Lonicera flower mango drip pill and its preparation method | |
| CN100367937C (en) | Throat dripping pill for clearing away heat and toxic material and its preparing method | |
| CN100358503C (en) | Compound cynomorium drip pill and its preparation method | |
| CN100358504C (en) | Gastrodia brain arousing drip pill for nourishing liver and kidney and its preparation method | |
| CN100348173C (en) | Drop pills of honeysuckle flower in use for clearing away heat and toxic materials and preparing method | |
| CN100364537C (en) | Cepharanthine drip pill and its preparation method | |
| CN100542519C (en) | It with the Flos lupuli extractum pulmonary-toxin-clearing dropping pill of raw material and preparation method thereof | |
| CN100382787C (en) | Quick acting toothache relieving dripping pills and its preparation method | |
| CN100427072C (en) | Constipation relieving dripping pills with rhubarb and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: BEIJING WEILI KANGYUAN MEDICAL TECHNOLOGY DEVELOPM Free format text: FORMER OWNER: BEIJING ZHENGDA OASIS MEDICINE TECHNOLOGY CO., LTD. Effective date: 20101027 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100176 201, 2/F, TOWER B, CHUANGXIN BUILDING, NO.12, HONGDA NORTH ROAD, ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE, BEIJING TO: 101100 NO.1182, BUILDING 1, YALI SHIJU, TONGZHOU DISTRICT, BEIJING |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20101027 Address after: 101100 Beijing city Tongzhou District Alice lived in Building 1, No. 1182 Patentee after: Beijing Weili Kangyuan Pharmaceutical Technology Development Co Ltd Address before: 100176 Beijing economic and Technological Development Zone Hongda North Road, building, No. two, block B, floor 201 Patentee before: Beijing Zhengda Oasis Medicine Technology Co., Ltd. |
|
| DD01 | Delivery of document by public notice |
Addressee: Shao Chunling Document name: Notification of Passing Examination on Formalities |
|
| DD01 | Delivery of document by public notice |
Addressee: Beijing Weili Kangyuan Pharmaceutical Technology Development Co Ltd Document name: Notification to Pay the Fees |
|
| DD01 | Delivery of document by public notice |
Addressee: Beijing Weili Kangyuan Pharmaceutical Technology Development Co Ltd Document name: Notification of Termination of Patent Right |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080319 Termination date: 20130526 |